AGP Executive Report
Last update: 10 hours agoCancer Care Breakthrough Loss: Australian melanoma pioneer Richard Scolyer has died at 59, three years after an aggressive brain tumour diagnosis that led to a world-first experimental glioblastoma treatment. Global Health Innovation: A University of Maryland team reports early clinical results for a dual Lassa fever and rabies vaccine, showing safety and immune responses—no licensed Lassa vaccine exists yet. Drug Safety Warning: The EU drug agency flags dangerous synthetic opioids in fake medicines, warning they can spread fast and cause severe harm before systems react. Access & Affordability: Florida’s MMJ Health is offering $99 first-time medical marijuana evaluations statewide through June 2026. Policy & Training: U.S. medical schools add nutrition education—19 more programs commit to at least 40 hours, bringing the total to 73. Healthcare Under Pressure: A Nepali mountaineer, Dawa Sherpa, survives after six days stranded on Everest and is moved from ICU to the ward as he recovers from frostbite, dehydration, and a fractured thigh bone. Regulatory/Market Watch: SBI is reportedly set to back Sun Pharma’s $12B Organon acquisition with up to $1B in funding.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
![<![CDATA[Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner]]>](https://cdn.sanity.io/images/0vv8moc6/pharmexec/8cb4a1bc0ee1ff12d8b0a9798f51811b39c390f0-8256x5504.jpg)
![[Trending] Cancer Medicine Market Size Expected to Hit USD 279.87 Billion by 2034, With 12.51% CAGR](https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg)
